1/12
07:17 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/12
06:10 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
1/12
06:10 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
1/7
10:57 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $500.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $500.00 price target on the stock.
12/15
03:39 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
12/11
08:15 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/11
09:22 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/11
09:22 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
10/31
11:13 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
10/31
11:13 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
10/31
07:19 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
10/30
04:24 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
10/30
04:24 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY